Navigation Links
Roskamp Institute Wins Grant for Lung Cancer Research

James & Esther King Biomedical Research Program Awards Peer-Reviewed Grant

SARASOTA, Fla., June 10 /PRNewswire/ -- The Roskamp Institute (Roskamp) today announced it was awarded the Florida Department of Health and James & Esther King Biomedical Research Program, Small Business Technology Transfer Grant for its advanced cancer research in using B-amyloid protein to stop the growth of lung cancer.

The grant in the amount of $100,000 was awarded to Roskamp's Investigator Daniel Paris, Ph.D. based on the scientific merit score Roskamp's proposal received through a competitive and qualified peer review process and the consideration of other factors by the Biomedical Research Advisory Council.

"This grant brings us one step closer to stopping the growth of lung cancer through our continued research with the use of B-amyloid protein," said Paris. "We are excited to have been awarded this grant, and we look forward to the advances we intend to make through our Institute's anti-cancer technology."

The peer-reviewed grant given to Roskamp for the "Treatment of Lung Adenocarcinoma and Metastasis by Anti-angiogenic Fragments of Abeta" project commences on July 1, 2008, and the life of the grant will be overseen by a grant manager of the James & Esther King Biomedical Research Program.

"The James & Esther King Program is known for its highly competitive grant award process, and we are honored to be a recipient," said Dr. Michael Mullan, director of Roskamp. "As a member of Florida's research community, we are committed to using this collaborative opportunity with small biomedical businesses and researchers alike to further our research advancements in hopes of curing this devastating disease."

The Roskamp Institute is a not-for-profit research Institute located in Sarasota and Tampa, Florida, that is dedicated to understanding the causes of, and finding cures for, neuropsychiatric and neurodegenerative disorders and addictions with an emphasis on Alzheimer's disease. Roskamp's Memory Centers also offer comprehensive cognitive and medical assessment toward differential diagnosis of Alzheimer's disease and offers treatments and disease management options once the diagnostic evaluation is complete.

For more information, please contact the Roskamp Institute in Sarasota at (941) 752-2949, the Roskamp Institute Clinical Trials Division in Sarasota at (941) 256-8018, the Roskamp Institute Memory Center in Tampa at (813) 979-2008, or visit us online at

SOURCE Roskamp Institute
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
2. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
3. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
4. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
5. Solazyme Selected for National Institute of Standards and Technology Award
6. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
7. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
8. National Institutes of Health Awards $25.5M Contract to SRA
9. The USC Stevens Institute for Innovation Opens Shop on US Health Sciences Campus
10. Infectious Disease Research Institute Receives Grant for Acquisition of Core Research Equipment from M.J. Murdock Charitable Trust
11. The USC Stevens Institute for Innovation Opens Shop on USC Health Sciences Campus
Post Your Comments:
(Date:10/11/2017)... ... ... Personal eye wash is a basic first aid supply for any work environment, but most ... you rinse first if a dangerous substance enters both eyes? It’s one less decision, and ... unique dual eye piece. , “Whether its dirt and debris, or an acid or alkali, ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... ... October 10, 2017 , ... San Diego-based team building and cooking events ... announced today. The bold new look is part of a transformation to increase ... a significant growth period. , It will also expand its service offering from its ...
(Date:10/10/2017)... , Oct. 10, 2017 International research firm Parks ... Strategy, will speak at the TMA 2017 Annual Meeting , October ... trends in the residential home security market and how smart safety and ... Parks ... "The residential ...
Breaking Biology Technology:
(Date:8/15/2017)... HAMPTON, Va. , Aug. 15 2017   ivWatch LLC ... effectiveness of intravenous (IV) therapy, today announced receipt of its ISO ... (QMS) developed by the International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for ... "This ...
(Date:5/23/2017)... first robotic gym for the rehabilitation and functional motor sense evaluation of ... Italy . The first 30 robots will be available from June ... . The technology was developed and patented at the IIT laboratories and ... thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:4/19/2017)... 19, 2017 The global military ... is marked by the presence of several large global ... by five major players - 3M Cogent, NEC Corporation, ... for nearly 61% of the global military biometric market ... the global military biometrics market boast global presence, which ...
Breaking Biology News(10 mins):